Published in Am J Gastroenterol on February 19, 2013
Study of a Dietary Supplement for Reflux During Sleep (SXDSFRS) | NCT02274636
A Prospective, Observational Study of the PPI Non-responder | NCT03282084
Fundoplication versus medical management of gastroesophageal reflux disease: systematic review and meta-analysis. Surg Endosc (2013) 2.07
Do endoscopic antireflux procedures fit in the current treatment paradigm of gastroesophageal reflux disease? Clin Gastroenterol Hepatol (2013) 2.05
Dual Ambulatory pH Monitoring in Patients with Gastroesophageal Reflux Rendered Asymptomatic with Proton Pump Inhibitor Therapy. Dig Dis Sci (2014) 1.54
Lifestyle Intervention in Gastroesophageal Reflux Disease. Clin Gastroenterol Hepatol (2015) 1.47
Acid-based parameters on pH-impedance testing predict symptom improvement with medical management better than impedance parameters. Am J Gastroenterol (2014) 1.09
Non-erosive reflux disease is more complex than negative endoscopy only. Am J Gastroenterol (2013) 1.09
Stretta radiofrequency treatment for GERD: a safe and effective modality. Am J Gastroenterol (2013) 1.03
Long-Term Proton Pump Inhibitor Use Is Not Associated With Changes in Bone Strength and Structure. Am J Gastroenterol (2016) 1.02
Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO Randomized Clinical Trial. Surg Innov (2014) 1.01
Optimal adaptive two-stage designs for early phase II clinical trials. Stat Med (2015) 0.98
The impact of proton pump inhibitors on the human gastrointestinal microbiome. Clin Lab Med (2014) 0.97
Stretta for refractory GERD: now more than ever. Am J Gastroenterol (2013) 0.96
Predictive factors of response to proton pump inhibitors in korean patients with gastroesophageal reflux disease. J Neurogastroenterol Motil (2015) 0.96
Diagnosis and treatment of gastroesophageal reflux disease. World J Gastrointest Pharmacol Ther (2014) 0.95
LINX(®) Reflux Management System in chronic gastroesophageal reflux: a novel effective technology for restoring the natural barrier to reflux. Therap Adv Gastroenterol (2013) 0.95
Efficacy of transoral fundoplication for treatment of chronic gastroesophageal reflux disease incompletely controlled with high-dose proton-pump inhibitors therapy: a randomized, multicenter, open label, crossover study. BMC Gastroenterol (2014) 0.94
Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression. BMC Med (2016) 0.92
Pre-operative clinical and instrumental factors as antireflux surgery outcome predictors. World J Gastrointest Surg (2016) 0.91
Long-Term PPI Use: Balancing Potential Harms and Documented Benefits. Am J Gastroenterol (2016) 0.90
Idiopathic (primary) achalasia: a review. Orphanet J Rare Dis (2015) 0.90
The role of obesity in oesophageal cancer development. Therap Adv Gastroenterol (2014) 0.90
Optimal treatment of laryngopharyngeal reflux disease. Ther Adv Chronic Dis (2013) 0.90
Refractory chronic cough due to gastroesophageal reflux: Definition, mechanism and management. World J Methodol (2015) 0.89
Use of Acid Suppression Medication is Associated With Risk for C. difficile Infection in Infants and Children: A Population-based Study. Clin Infect Dis (2015) 0.89
Common Mechanism of Pathogenesis in Gastrointestinal Diseases Implied by Consistent Efficacy of Single Chinese Medicine Formula: A PRISMA-Compliant Systematic Review and Meta-Analysis. Medicine (Baltimore) (2015) 0.88
Sex and Gender Differences in Gastroesophageal Reflux Disease. J Neurogastroenterol Motil (2016) 0.87
Diagnostic indicators of non-cardiovascular chest pain: a systematic review and meta-analysis. BMC Med (2013) 0.87
Gastroesophageal reflux disease in COPD: links and risks. Int J Chron Obstruct Pulmon Dis (2015) 0.85
Tryciclic Antidepressants in Refractory GERD: Poorly Effective Drugs or Wrong Patients? Am J Gastroenterol (2016) 0.85
Management of gastrointestinal involvement in scleroderma. Curr Treatm Opt Rheumatol (2015) 0.84
EAES recommendations for the management of gastroesophageal reflux disease. Surg Endosc (2014) 0.84
Echocardiographic manifestation of esophagitis mimicking a posterior mediastinal mass. Clin Med Insights Cardiol (2015) 0.83
The impact of comorbid gastroesophageal reflux disease on endoscopic sinus surgery quality-of-life outcomes. Int Forum Allergy Rhinol (2014) 0.83
Esophageal surgery in minimally invasive era. World J Gastrointest Surg (2016) 0.82
Intra-gastric pH following single oral administrations of rabeprazole and esomeprazole: double-blind cross-over comparison. J Clin Biochem Nutr (2014) 0.82
Gastroesophageal reflux disease: diagnosis and patient selection. Indian J Surg (2014) 0.82
Addition of prokinetics to PPI therapy in gastroesophageal reflux disease: a meta-analysis. World J Gastroenterol (2014) 0.82
[Chronic chest pain]. Schmerz (2014) 0.81
Boundary problem in Simon's two-stage clinical trial designs. J Biopharm Stat (2016) 0.81
Univariate and multivariate analyses of preoperative factors influencing symptomatic outcomes of transoral fundoplication. Surg Endosc (2014) 0.81
Development of quality measures for the care of patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol (2014) 0.81
Endoscopic treatment of refractory gastroesohageal reflux disease. Clin Endosc (2013) 0.81
Gastroesophageal reflux disease: A review of surgical decision making. World J Gastrointest Surg (2016) 0.80
Brand name and generic proton pump inhibitor prescriptions in the United States: insights from the national ambulatory medical care survey (2006-2010). Gastroenterol Res Pract (2015) 0.80
Computer versus physician identification of gastrointestinal alarm features. Int J Med Inform (2015) 0.80
Impairment of chemical clearance and mucosal integrity distinguishes hypersensitive esophagus from functional heartburn. J Gastroenterol (2016) 0.80
Effect of a Combination of Omeprazole Plus Sustained Release Baclofen Versus Omeprazole Alone on Symptoms of Patients with Gastroesophageal Reflux Disease (GERD). Iran J Pharm Res (2014) 0.80
GERD phenotypes from pH-impedance monitoring predict symptomatic outcomes on prospective evaluation. Neurogastroenterol Motil (2015) 0.80
Factors affecting response to proton pump inhibitor therapy in patients with gastroesophageal reflux disease: a multicenter prospective observational study. J Gastroenterol (2015) 0.79
Metoclopramide role in preventing ileus after cesarean, a clinical trial. Eur J Clin Pharmacol (2015) 0.79
Pantoprazole decreases cell viability and function of human osteoclasts in vitro. Mediators Inflamm (2015) 0.78
Risk of upper gastrointestinal cancers in patients with gastroesophageal reflux disease after a negative screening endoscopy. Clin Gastroenterol Hepatol (2014) 0.78
Recurrence and Its Impact on the Health-related Quality of Life in Patients with Gastroesophageal Reflux Disease: A Prospective Follow-up Analysis. J Neurogastroenterol Motil (2016) 0.78
Pharmacokinetics and pharmacodynamics of an orally disintegrating tablet formulation of dexlansoprazole. Therap Adv Gastroenterol (2016) 0.78
Validation and diagnostic usefulness of gastroesophageal reflux disease questionnaire in a primary care level in Mexico. J Neurogastroenterol Motil (2014) 0.78
Distal mean nocturnal baseline impedance on pH-impedance monitoring predicts reflux burden and symptomatic outcome in gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2016) 0.77
Prevalence, characteristics, and treatment outcomes of reflux hypersensitivity detected on pH-impedance monitoring. Neurogastroenterol Motil (2016) 0.77
The Intersection of GERD, Aspiration, and Lung Transplantation. J Laparoendosc Adv Surg Tech A (2016) 0.77
Sleeve gastrectomy and gastroesophageal reflux disease. J Obes (2013) 0.77
Autofluorescence imaging endoscopy can distinguish non-erosive reflux disease from functional heartburn: A pilot study. World J Gastroenterol (2016) 0.77
Impedance pH Guided Approach to Proton Pump Inhibitor-refractory Non-erosive Reflux Disease. J Neurogastroenterol Motil (2014) 0.77
Multilayered epithelium at the gastroesophageal junction is a marker of gastroesophageal reflux disease: data from a prospective Central European multicenter study (histoGERD trial). Virchows Arch (2014) 0.77
Gastrointestinal morbidity in obesity. Ann N Y Acad Sci (2014) 0.77
Advances in the evaluation and management of esophageal disease of systemic sclerosis. Curr Rheumatol Rep (2015) 0.77
The role of the pharmacist in the selection and use of over-the-counter proton-pump inhibitors. Int J Clin Pharm (2015) 0.77
Laparoscopic fundoplication for gastroesophageal reflux disease. World J Gastroenterol (2014) 0.76
The Pathogenesis and Management of Achalasia: Current Status and Future Directions. Gut Liver (2015) 0.76
Highlights From the New ACG Guidelines for the Diagnosis and Management of GERD. Gastroenterol Hepatol (N Y) (2013) 0.76
Diagnosis and Anti-Reflux Therapy for GERD with Respiratory Symptoms: A Study Using Multichannel Intraluminal Impedance-pH Monitoring. PLoS One (2016) 0.76
Persistent gastro-oesophageal reflux symptoms despite proton pump inhibitor therapy. Singapore Med J (2016) 0.76
Reflux esophagitis in war-related sulfur mustard lung disease. Med J Islam Repub Iran (2014) 0.76
A Study to Draw a Normative Database of Laryngopharynx pH Profile in Chinese. J Neurogastroenterol Motil (2014) 0.76
Managing gastroesophageal reflux disease - comparative efficacy and outcomes of dexlansoprazole MR. Ther Clin Risk Manag (2015) 0.76
Expert consensus document: Advances in the physiological assessment and diagnosis of GERD. Nat Rev Gastroenterol Hepatol (2017) 0.76
25 Years of Proton Pump Inhibitors: A Comprehensive Review. Gut Liver (2016) 0.76
Effects of acotiamide on esophageal motor function and gastroesophageal reflux in healthy volunteers. BMC Gastroenterol (2015) 0.75
Revision of failed transoral incisionless fundoplication by subsequent laparoscopic Nissen fundoplication. World J Gastroenterol (2014) 0.75
Adult and paediatric GERD: diagnosis, phenotypes and avoidance of excess treatments. Nat Rev Gastroenterol Hepatol (2016) 0.75
Reflux characteristics of 113 GERD patients with abnormal 24-h multichannel intraluminal impedance-pH tests. J Zhejiang Univ Sci B (2015) 0.75
Outcomes of fundoplication for paediatric gastroesophageal reflux disease. Pediatr Surg Int (2015) 0.75
Monitoring for GE Reflux: Is Normal the New Normal? Dig Dis Sci (2015) 0.75
Clinical Manifestations of Laryngopharyngeal Reflux. J Neurogastroenterol Motil (2016) 0.75
The management of gastro-oesophageal reflux disease. Aust Prescr (2016) 0.75
Effect of Helicobacter pylori eradication on reflux esophagitis therapy: a multi-center randomized control study. Chin Med J (Engl) (2015) 0.75
Test-based exclusion diets in gastro-esophageal reflux disease patients: a randomized controlled pilot trial. World J Gastroenterol (2014) 0.75
A stepwise protocol for the treatment of refractory gastroesophageal reflux-induced chronic cough. J Thorac Dis (2016) 0.75
Analysis of clinical characteristics and causes of chest pain in children and adolescents. Korean J Pediatr (2015) 0.75
A Model for Predicting the Future Risk of Incident Erosive Esophagitis in an Asymptomatic Population Undergoing Regular Check-ups. Medicine (Baltimore) (2016) 0.75
Upper aerodigestive tract disorders and gastro-oesophageal reflux disease. World J Clin Cases (2015) 0.75
Nickel sensitization in patients with gastro-esophageal reflux disease. United European Gastroenterol J (2015) 0.75
Transoral incisionless fundoplication: current status. Curr Opin Gastroenterol (2016) 0.75
The efficacy and safety of proton-pump inhibitors in treating patients with non-erosive reflux disease: a network meta-analysis. Sci Rep (2016) 0.75
The American Journal of Gastroenterology in 2016: Where Have We Been? Where Are We Going? Am J Gastroenterol (2016) 0.75
Effects of Transcutaneous Electrical Acustimulation on Refractory Gastroesophageal Reflux Disease. Evid Based Complement Alternat Med (2016) 0.75
Unintentional Discontinuation of Chronic Medications for Seniors in Nursing Homes: Evaluation of a National Medication Reconciliation Accreditation Requirement Using a Population-Based Cohort Study. Medicine (Baltimore) (2015) 0.75
Association between Gastroesophageal Reflux Disease and Appendicitis: A Population-Based Case-Control Study. Sci Rep (2016) 0.75
Discrepancies between upper GI symptoms described by those who have them and their identification by conventional medical terminology: a survey of sufferers in four countries. Eur J Gastroenterol Hepatol (2016) 0.75
Gastrointestinal problems in modern wars: clinical features and possible mechanisms. Mil Med Res (2015) 0.75
Impact of obesity treatment on gastroesophageal reflux disease. World J Gastroenterol (2016) 0.75
Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach. Arch Intern Med (2006) 3.84
ACG clinical guideline: diagnosis and management of achalasia. Am J Gastroenterol (2013) 3.20
Risk of perforation from a colonoscopy in adults: a large population-based study. Gastrointest Endosc (2009) 2.78
Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal and intragastric pH in patients with gastroesophageal reflux disease (GERD). Am J Gastroenterol (2004) 2.02
Jejunal diverticulosis diagnosed by double-balloon enteroscopy. Gastrointest Endosc (2006) 1.59
Pneumatic dilation for the treatment of achalasia in untreated patients and patients with failed Heller myotomy. J Clin Gastroenterol (2004) 1.57
Esophageal-reflux monitoring. Gastrointest Endosc (2009) 1.49
Esophageal function testing with combined multichannel intraluminal impedance and manometry: multicenter study in healthy volunteers. Clin Gastroenterol Hepatol (2003) 1.48
Endoscopic mucosal resection for early esophageal cancer--replacement for esophagectomy? Gastroenterology (2008) 1.40
An analysis of persistent symptoms in acid-suppressed patients undergoing impedance-pH monitoring. Clin Gastroenterol Hepatol (2008) 1.29
Multichannel intraluminal impedance in esophageal function testing and gastroesophageal reflux monitoring. J Clin Gastroenterol (2003) 1.28
Preoperative diagnostic workup before antireflux surgery: an evidence and experience-based consensus of the Esophageal Diagnostic Advisory Panel. J Am Coll Surg (2013) 1.16
Chemical colitis. J Clin Gastroenterol (2008) 1.16
Characteristics of symptomatic reflux episodes on Acid suppressive therapy. Am J Gastroenterol (2008) 1.14
Distal esophageal spasm: an update. Curr Gastroenterol Rep (2013) 1.06
Double-balloon enteroscopy: the new gold standard for small-bowel imaging? Gastrointest Endosc (2005) 1.03
Barrett's esophagus: Incidence, etiology, pathophysiology, prevention and treatment. Ther Clin Risk Manag (2007) 1.00
Cost-effectiveness model of endoscopic biopsy for eosinophilic esophagitis in patients with refractory GERD. Am J Gastroenterol (2011) 0.98
Features of gastroesophageal reflux disease in women. Am J Gastroenterol (2004) 0.93
Preservation and Incorporation of Valuable Endoscopic Innovations (PIVI) on the use of endoscopy simulators for training and assessing skill. Gastrointest Endosc (2012) 0.90
Impact of inpatient status and gender on small-bowel capsule endoscopy findings. Gastrointest Endosc (2011) 0.90
Risk of proximal colon neoplasia with distal hyperplastic polyps: a meta-analysis. Arch Intern Med (2005) 0.90
Long-term impact of capsule endoscopy in patients referred for iron-deficiency anemia. Dig Dis Sci (2009) 0.88
Comparison of reflux frequency during prolonged multichannel intraluminal impedance and pH monitoring on and off acid suppression therapy. J Clin Gastroenterol (2009) 0.87
Can colonoscopy simulators enhance the learning curve for trainees? Gastrointest Endosc (2006) 0.85
The effect of oral buspirone, pyridostigmine, and bethanechol on esophageal function evaluated with combined multichannel esophageal impedance-manometry in healthy volunteers. J Clin Gastroenterol (2009) 0.84
An analysis of distal esophageal impedance in individuals with and without esophageal motility abnormalities. J Clin Gastroenterol (2008) 0.83
Acute colitis secondary to self-administered alcohol enemas: a mimic of ischemic colitis. J Clin Gastroenterol (2005) 0.81
New esophageal function testing (impedance, Bravo pH monitoring, and high-resolution manometry): clinical relevance. Curr Gastroenterol Rep (2008) 0.79
Barrett's esophagus: surveillance and reversal. Ann N Y Acad Sci (2011) 0.79
Profile of GERD in the adult population of a northeast urban community. J Clin Gastroenterol (2004) 0.79
Risk factors for the detection of Barrett's esophagus in patients with erosive esophagitis. Gastrointest Endosc (2009) 0.78
Is there a role for angiography in patients with obscure overt bleeding? Am J Gastroenterol (2012) 0.78
Barrett's esophagus: endoscopic diagnosis. Ann N Y Acad Sci (2011) 0.78
Long-term outcomes after single-balloon enteroscopy: are they any different from double-balloon enteroscopy for vascular lesions? Dig Dis Sci (2013) 0.77
Corrigendum: ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus. Am J Gastroenterol (2016) 0.76
The future of simulators in GI endoscopy: an unlikely possibility or a virtual reality? Gastrointest Endosc (2002) 0.75
Do pregnant women with heartburn become adults with GERD? Gastroenterology (2008) 0.75
Pneumatic dilation or myotomy for achalasia? Gastroenterology (2007) 0.75
Initial capsule endoscopy or angiography in patients with obscure gastrointestinal bleeding? Gastroenterology (2007) 0.75
Too late for tegaserod? Efficacy for treatment of constipation in men. Gastroenterology (2007) 0.75
Comparison of health care resource utilization and costs among patients with GERD on once-daily or twice-daily proton pump inhibitor therapy. Clinicoecon Outcomes Res (2013) 0.75
Effect of heartburn on life expectancy. Gastroenterology (2008) 0.75
Small bowel imaging for Crohn's disease: camera, contrast, or scope? Gastroenterology (2009) 0.75
Screening for esophageal varices: is esophageal capsule endoscopy ready for prime time? J Clin Gastroenterol (2009) 0.75
Response to Savarino et al. Am J Gastroenterol (2013) 0.75
Should all patients with acute gastrointestinal hemorrhage receive intravenous proton pump inhibitor therapy before endoscopy? Gastroenterology (2008) 0.75
Response to Franciosa et al. and Triadafilopoulos. Am J Gastroenterol (2013) 0.75
Are all proton pump inhibitors created equal? Gastroenterology (2007) 0.75
Bariatric surgery and life expectancy. Gastroenterology (2008) 0.75
Time to consider medical therapy for small-bowel angioectasias. Am J Gastroenterol (2012) 0.75
Impedance-pH testing. Gastroenterol Clin North Am (2013) 0.75
Development of a Preliminary Question Prompt List as a Communication Tool for Adults With Achalasia: A Modified Delphi Study. J Clin Gastroenterol (2022) 0.75
A little weight gain, how much gastroesophageal reflux disease? Gastroenterology (2006) 0.75
A case of iron-deficiency anemia. Clin Gastroenterol Hepatol (2006) 0.75
[Gastroesophageal Reflux Disease Review (GERD)]. Acta Gastroenterol Latinoam (2017) 0.75